Eratia

Eratia is an intravenous antibiotic combining piperacillin and tazobactam, used to treat bacterial infections. This medication is manufactured by Medochemie Ltd. in the EU.

Eratia is primarily used to treat bacterial infections in patients requiring intravenous antibiotics. The combination of piperacillin and tazobactam works to combat a range of bacterial strains, often prescribed for severe or complicated infections. Healthcare providers may recommend Eratia for conditions where broad-spectrum antibiotic coverage is necessary.

Common effects of Eratia may include mild to moderate reactions at the injection site, such as redness or swelling. Some patients might experience gastrointestinal discomfort, including nausea or diarrhea. Allergic reactions, though rare, can occur and should be reported to a healthcare professional immediately.

Eratia should be used with caution in patients with a history of allergic reactions to penicillin or beta-lactam antibiotics. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking. Proper administration by a healthcare professional is crucial to minimize risks.

Eratia may interact with certain medications, including other antibiotics, blood thinners, and drugs that affect kidney function. Alcohol should be avoided as it can exacerbate side effects. Always consult a healthcare provider before starting or stopping any medication.